Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Gonzalez-Angulo

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Cancer Treatment Reviews|December 11, 2012
Defining biomarkers to predict sensitivity to PI3K/Akt/mTOR pathway inhibitors in breast cancerA M Gonzalez-Angulo, G R Blumenschein
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 18, 2011
Stability of HER2-positive status in breast carcinoma: a comparison between primary and paired metastatic tumors with regard to the possible impact of intervening trastuzumab treatmentC Xiao, Y Gong, E Y Han, et al.
British Journal of Cancer|February 11, 2015
A preoperative nomogram to predict the risk of synchronous distant metastases at diagnosis of primary breast cancerC Boutros, C Mazouni, F Lerebours, et al.
Drugs of Today (Barcelona, Spain : 1998)|March 25, 2011
Quantitative proteomic analysis in breast cancerA Tabchy, B T Hennessy, A M Gonzalez-Angulo, et al.
Breast Cancer Research and Treatment|March 6, 2013
The prognostic impact of age in patients with triple-negative breast cancerCornelia Liedtke, K R Hess, T Karn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 2014
Survival of women with inflammatory breast cancer: a large population-based studyS Dawood, X Lei, R Dent, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 9, 2013
Functional proteomics characterization of residual triple-negative breast cancer after standard neoadjuvant chemotherapyJ Sohn, K A Do, S Liu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2011
Identifying factors that impact survival among women with inflammatory breast cancerS Dawood, N T Ueno, V Valero, et al.
British Journal of Cancer|January 14, 2015
Effect of adjuvant trastuzumab among patients treated with anti-HER2-based neoadjuvant therapyA M Gonzalez-Angulo, N Parinyanitikul, X Lei, et al.
Breast Cancer Research and Treatment|August 15, 2016
Clinicopathological and surgical factors associated with long-term survival in patients with HER2-positive metastatic breast cancerK Harano, X Lei, A M Gonzalez-Angulo, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Cancer Treatment Reviews|December 11, 2012
Defining biomarkers to predict sensitivity to PI3K/Akt/mTOR pathway inhibitors in breast cancerA M Gonzalez-Angulo, G R Blumenschein
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 18, 2011
Stability of HER2-positive status in breast carcinoma: a comparison between primary and paired metastatic tumors with regard to the possible impact of intervening trastuzumab treatmentC Xiao, Y Gong, E Y Han, et al.
British Journal of Cancer|February 11, 2015
A preoperative nomogram to predict the risk of synchronous distant metastases at diagnosis of primary breast cancerC Boutros, C Mazouni, F Lerebours, et al.
Drugs of Today (Barcelona, Spain : 1998)|March 25, 2011
Quantitative proteomic analysis in breast cancerA Tabchy, B T Hennessy, A M Gonzalez-Angulo, et al.
Breast Cancer Research and Treatment|March 6, 2013
The prognostic impact of age in patients with triple-negative breast cancerCornelia Liedtke, K R Hess, T Karn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 2014
Survival of women with inflammatory breast cancer: a large population-based studyS Dawood, X Lei, R Dent, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 9, 2013
Functional proteomics characterization of residual triple-negative breast cancer after standard neoadjuvant chemotherapyJ Sohn, K A Do, S Liu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2011
Identifying factors that impact survival among women with inflammatory breast cancerS Dawood, N T Ueno, V Valero, et al.
British Journal of Cancer|January 14, 2015
Effect of adjuvant trastuzumab among patients treated with anti-HER2-based neoadjuvant therapyA M Gonzalez-Angulo, N Parinyanitikul, X Lei, et al.
Breast Cancer Research and Treatment|August 15, 2016
Clinicopathological and surgical factors associated with long-term survival in patients with HER2-positive metastatic breast cancerK Harano, X Lei, A M Gonzalez-Angulo, et al.
Pageof 3